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To evaluate the basis of the slow growth of many human immunodeficiency virus strains in monocytes/
macrophages, various stages of the virus life cycle have been studied for their possible contribution to viral tropism.
Although we found that monocytic U937 cells had a higher percentage of CD4-positive cells than T-lymphoid H9
cells, the human immunodeficiency virus strain grew much less efficiently in the monocytic line. Viral tropism was
primarily determined during the early stages of the virus cycle, that is, sometime between binding of the virus to
the cell surface and reverse transcription of viral genomic RNA. Once the virus entered the host cell, reverse
transcription, use of the long terminal repeat, RNA expression, and production of virus particles was about as
efficient in monocytes as in T cells. Thus, during viral entry into the host cell cytoplasm there is a major limiting
event that is particularly inefficient in U937 cells and possibly in all monocytes/macrophages.
The major cell types thought to be targets for human
immunodeficiency virus (HIV) are T lymphocytes and
monocytes/macrophages. Both display surface CD4 mole-
cule, the known HIV receptor protein, and both are thought
to be cellular reservoirs for HIV in infected people (for
recent reviews, see references 10 and 15; 35). Certain strains
of HIV grow well in T cells but poorly in monocytes/
macrophages, while others exhibit the opposite growth pat-
tern (9, 14). Understanding such viral tropism is vital to
unraveling the pathogenetic mechanisms of HIV.
The retroviral life cycle consists of the processes of viral
entry, reverse transcription of the RNA genome, integration
of viral DNA, transcription, translation, posttranslational
modification including protein processing, and assembly of
the virus particle. Formally, the efficiency of viral growth,
and eventually viral tropism, can be determined at any stage
of the life cycle. For example, the main receptor of HIV is
CD4 on the cell surface (7, 28), and thus its levels can
influence the efficiency of viral infection; susceptibility to
HIV infection generally, but not always, correlates with CD4
expression in host cells (1, 3). It has also been shown that
intracellular levels of deoxyribonucleotides, the substrates
for reverse transcription, can vary between host cells (19),
suggesting that the rate of reverse transcription can be a
factor affecting viral growth if multiple superinfection oc-
curs. Complex interaction between viral and cellular factors
is more evident at the level of gene expression, thereby
affecting viral growth and tropism. The HIV long terminal
repeat (LTR) interacts with a number of cellular factors
whose expression is also modulated (13, 21, 31; for a recent
review, see reference 24). The interplay of the various
regulators, both viral and cellular, generates early and late
transcriptional phases in the HIV life cycle; the earliest RNA
is enriched in subgenomic species, while the genomic tran-
script appears at the later stage of infection (22). It is also
possible that viral regulatory proteins, such as Tat and Rev,
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interact with cellular factors, because the magnitude of
trans-activation of the HIV LTR by Tat varies between cell
types and species (2, 6, 27, 29).
We have studied factors affecting viral tropism by analyz-
ing the major stages of the virus life cycle during infection of
different cell types. We have chosen well-known T-lympho-
cyte and monocyte cell lines which are CD4-positive but
support very different rates of viral growth. Surprisingly, we
found that slow viral growth in monocytic cells is largely due
to inefficient viral entry, despite their high levels of surface
CD4, and that all other steps of the virus life cycle appear to
be as efficient in monocytic cells as in T cells.
MATERIALS AND METHODS
Cells, virus, and infection. Host cells for HIV infection
were H9 (34) and U937 (37), T-lymphoid and monocytic cell
lines, respectively. The levels of CD4 on the cell surface of
these cells were analyzed by a fluorescence-activated cell
sorter as described by Crowe et al. (5) using monoclonal
antibody Leu3a (Becton Dickinson) against CD4 and Leu2a
(Becton Dickinson) recognizing CD8 as a control monoclo-
nal antibody. The viral strain used throughout this study was
HIV-1-WI3 (22), which grows preferentially in T cells. Viral
production was initiated by transfecting the plasmid pWI3
into H9 or COS cells. A high-titer preparation of viral stock
was made by the shaking method as described previously
(22, 39). Host cells were exposed to virus at 37TC for 1.5 h.
They were then washed with medium and divided among an
appropriate number of culture flasks. When H9 and U937
cells were compared for their infection by HIV, the same
number of H9 and U937 cells were infected with equal
quantities of virus by dividing freshly prepared virus pre-
cisely into two aliquots. At appropriate time points, samples
were taken for reverse transcriptase assay (33), indirect
immunofluorescence assay (20), viable-cell count, DNA, and
RNA hybridization analysis.
Plasmids and transfection. The HIV LTR-CAT plasmid
was constructed by ligating the KpnI-HindIII fragment of
HIV type 1 LTR into the PvuII-to-HindIII sites of pSV918.
pSV918 is identical to pSVECAT (16), except that the
pBR322 backbone was replaced by SP65 (30). In the plasmid
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pSV-TAT, the tat coding region is driven by the simian virus
40 early promoter (8). Transfection ofH9 and U937 cells was
performed by the DEAE-dextran technique (36), as modified
by Grosschedl and Baltimore (18) with 2 mg of HIV LTR-
CAT and 4 mg of pSV-TAT plasmids per 107 cells. Chlor-
amphenicol acetyltransferase (CAT) assays were performed
by the procedure of Gorman et al. (16) with 20 to 30 mg of
protein for each determination. The percentage of chloram-
phenicol that was acetylated was determined as described by
Pierce et al. (32). To assess transfection efficiency, cells
were transfected with pWI3 (22) which contains the whole
viral genome. Forty-eight hours after transfection, the per-
centage of transfected cells was determined by measuring
immunofluorescence-positive cells using human sera.
DNA and RNA blot hybridization. Preparation of the total
DNA fraction (including low- and high-molecular-weight
DNA), RNA, and the probe used for DNA hybridization
analysis were as described by Kim et al. (22). The probe
used for RNA hybridization analysis was antisense RNA,
complementary to the 511-bp BglII fragment of the HIV
LTR, which includes the polyadenylation signal sequence.
RESULTS
Inefficient viral growth in U937. The viral strain used in this
study was HIV-1-WI3 (22). This strain was derived from one
of several molecular clones from HIV-1IIIB (34) and has been
characterized previously (22, 23). The WI3 strain grows
much less efficiently in monocytic cell lines than in T-lym-
phoid cell lines. In a particular infection (Fig. 1), HIV rapidly
spread through the H9 culture soon after initial infection.
The time point showing the highest percentage of infected
cells (assayed by indirect immunofluorescence using human
sera) or the highest reverse transcriptase activity in cell
culture supernatants was obtained within 6 to 8 days after
infection in H9 cells. In contrast, virus grew very slowly for
the first 10 days in U937 cells, but more rapidly thereafter.
Still, it took nearly 30 days to reach the peak of infection in
U937 cells. Eventually, HIV infected 90 to 95% of cells in
both cell types, and it was reproduicibly found that the peak
reverse transcriptase activity was higher in U937 cells than
in H9 cells. Changes in the titer of the viral inoculum used
for initial infection changed the length of the lag phase in the
two cell types, but not the striking difference in the time
required for the virus to reach the infection peak.
CD4 is not a limiting factor. To test whether surface CD4
concentration was a limiting factor for viral growth in U937
cells, we measured CD4 on the cell surface by fluorescence-
activated cell sorter analysis. The apparent percentage of
CD4-positive cells (recognized by Leu3a) was 43 and 100%
in H9 and U937 cells, respectively (Fig. 2). The mean value
for the level of CD4 in U937 cells was 1.6 times higher than
in H9 cells. These results indicated that CD4 on the cell
surface was not a limiting factor for viral growth in U937
cells.
LTR is used efficiently. There are many lines of evidence
that the LTR of HIV plays a major role in viral gene
expression (13, 21, 31; for a recent review, see reference 24).
Therefore, using a transient transfection assay, we com-
pared the degree of expression driven by the HIV LTR in
U937 and H9 cells. An HIV LTR-CAT construct was
transfected into each cell type with or without a tat expres-
sion vector (8), and transient expression of the bacterial
CAT was used to compare the activities of the HIV LTR.
For quantitative comparison, the same number of cells and
the same quantity of plasmids were used in the transfection.
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FIG. 1. Growth of HIV in H9 (0) and U937 (0) cells. Change in
the percentage of immunofluorescence-positive cells (IF) using
human sera or change in reverse transcriptase activity (RT) in cell
culture supernatant. Note that a high titer of viral stock was used for
the infection shown here. Under these conditions, we could syn-
chronously infect 5 to 10% of H9 cells but only 0.5 to 1% of U937
cells. A single-cycle growth condition is achieved during the first 24
to 32 h postinfection (22). When 1% of the same viral stock was
used, it took approximately 2 weeks for H9 cells and 2 to 3 months
for U937 cells to reach the infection peak.
The percentages of transfected cells, as measured by immu-
nofluorescence at 48 h after transfection, were 2 to 4% in
both cell types, indicating that the transfection efficiencies in
H9 and U937 cells were comparable. In both cell types, high
levels of CAT activity were readily detectable when the HIV
LTR-CAT plasmid was cotransfected with a tat expression
vector (Fig. 3). Although the magnitude of difference in the
LTR activity between the two cell types varied among the
different laboratory clones of U937 used for transfection, the
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FIG. 2. Fluorescence-activated cell sorter analysis of CD4.
Monoclonal antibody Leu3a (Becton Dickinson) against CD4 was
used, while Leu2a (Becton Dickinson) recognizing CD8 was used as
a control monoclonal antibody.
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FIG. 3. CAT analysis of the HIV LTR. Lanes: 1 and 3, HIV
LTR-CAT; 2 and 4, HIV LTR-CAT plus pSV-TAT. The result
shown in this figure represents only one of many independent
transfections. The transfection efficiency ranged from 2 to 4% in
different transfections; for a given transfection, the transfection
efficiencies in H9 and U937 cells were always comparable. C,
Chloramphenicol; Ac, acetylated chloramphenicol.
level of the CAT activity was always higher in U937 than in
H9 cells. This result was consistent with our observation
that the peak reverse transcriptase activity (Fig. 1) and RNA
level per infected cell (data not shown) were also somewhat
higher in U937 cells. This data suggests that the HIV LTR
region may not be an apparent determinant of viral tropism.
Differential control of RNA expression appears identical.
HIV shows a complex transcription pattern. We have pre-
viously shown that during HIV infection of T cells, there is
a temporal progression of RNA accumulation, with the 2-kb
subgenomic mRNA species being greatly enriched during
the early transcriptional phase (22). The rev gene has been
proposed to determine such differential RNA expression (22,
40). To investigate whether monocytes also show the same
pattern of RNA expression, total RNAs were prepared from
infected U937 cells at various time points before and after a
one-step growth cycle and assayed for viral RNA content by
electrophoretic separation and hybridization to a 32P-labeled
RNA probe (Fig. 4). During acute and chronic infection with
HIV, three RNA bands were normally seen by RNA blot
analysis (Fig. 4): the 9.2-kb band, which is both the genomic
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FIG. 4. Hybridization analysis of HIV RNA from a single-cycle
infection culture. Numbers above the lanes are hours postinfection,
while lane numbers are indicated at the bottom of HIV RNA panels.
Numbers next to the panel indicate approximate sizes ofRNA bands
(in kilobases). Antisense RNA complementary to the 511-bp BgII
fragment of pWI3 (8) was used as a probe.
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FIG. 5. Analysis of unintegrated HIV DNA. Numbers above the
lanes are hours postinfection, while those between two panels
indicate lane numbers. L and C are linear and circular DNA,
respectively. U indicates the -2.3-kb DNA bands used as DNA
loading controls. This is a yet uncharacterized cellular genomic
DNA which hybridized with our DNA probe (8) after XbaI digestion
of cellular DNA samples. This band was present in all human cell
lines and primary cells tested thus far. At present, it is not clear what
this DNA band represents. The intensities of DNA bands were
compared by laser densitometry (UltroScan laser densitometer
LKB2202).
RNA and the mRNA for the gag and pol genes; the 4.3-kb
species which includes env mRNA, as well as others, such as
those for the partially spliced tat message; and the 2-kb
mRNAs which encode the small regulatory genes such as
tat, rev, and nef. The ratio of radioactivity in the 2-, 4.3-, and
9.2-kb mRNAs in long-term infected cells is approximately 1
to 0.9 to 2.5. When RNAs from infected U937 cells were
analyzed, the first species, evident at 16 h postinfection, was
the 2-kb RNA, with a small quantity of the 4.3-kb RNAs
(Fig. 4). This corresponded to the pattern of early RNA
expression previously seen in T cells (22). Therefore, HIV
RNA expression in monocytes appears to be controlled in
the same sequential manner as in T cells, suggesting that
differential control of RNA expression may not be a major
factor determining viral tropism.
Viral tropism is determined during the early stages of the
virus life cycle. The above analyses suggested that the poor
growth of our HIV strain in U937 cells was not determined at
the level of gene expression. Therefore, we tested the
possible role of earlier events in the virus life cycle in
determining tropism. First, we measured the amount of
unintegrated HIV DNA shortly after infection in H9 and
U937 cells. This analysis determines the efficiencies of the
processes of viral entry and reverse transcription. Total
DNAs, including low- and high-molecular-weight DNA,
were prepared at various time points after the initial infec-
tion. We have previously described the detailed kinetics of
HIV DNA synthesis in T cells (8). The qualitative change of
DNA synthesis during a single-step growth cycle was found
to be essentially identical in both H9 and U937 cells; the
quantities of viral DNA gradually increased until 11 h after
infection and then decreased (Fig. 5). However, there was a
significant difference between the two cell types in the
quantity of linear DNA present, which is the major compo-
nent of unintegrated DNA. The quantity of HIV linear DNA
was reproducibly 5 to 10 times higher in H9 cells than in
U937 cells (Fig. 5). This indicates that a major factor causing
slow viral growth in U937 cells is in the early stages of the
HIV life cycle, which includes the processes of viral entry
and reverse transcription.
Viral entry is a major factor for determining viral growth.
To distinguish between the involvement of reverse transcrip-
tion and viral entry in viral tropism, we measured the
J. VIROL.
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FIG. 6. Analysis of cell-associated viral genomic RNA. Num-
bers above lanes are hours postinfection, while numbers between
panels indicate lane numbers. H and U are H9 and U937 cells,
respectively. The viral genomic RNA is indicated as an arrow. T,
ax-tubulin RNA used as RNA loading controls (9, 26).
amounts of viral genomic RNA soon after infection of each
cell type. For quantitative comparison, the same number of
H9 and U937 cells were infected with equal amounts of
virus, and cell-free virus was removed by washing infected
cells with medium. Total RNAs were prepared and analyzed
by RNA blot analysis. This analysis measures the amount of
virion genomic RNA associated with host cells, and thus
distinguishes the involvement of viral entry (including both
viral binding and penetration) and reverse transcription in
viral tropism. At 4 h after infection, the quantity of cell-
associated virion RNA was reproducibly 5- to 10-fold higher
in H9 cells than in U937 cells (Fig. 6). These results suggest
that a major limiting factor(s) for viral growth in U937 occurs
before the process of reverse transcription starts, probably
during the process of viral entry.
DISCUSSION
We have studied factors affecting the efficiency of HIV
infection in the monocytic cell line U937 as a model system
for understanding viral tropism. Our results suggest that
slow viral growth in U937 cells is due to inefficiency in the
early stages of the virus life cycle, that is, sometime between
binding of the virus to the cell surface and reverse transcrip-
tion of viral genomic RNA. Once the virus enters the host
cell, reverse transcription, use of the LTR, RNA expression,
and production of virus particles appear to be as efficient in
U937 cells as in H9 cells. We have also compared viral
growth characteristics in H9 and THP-1 cells. The latter is
another human monocytic cell line, which also contains
more surface CD4 than H9 cells (38). Again, HIV-1-W13
grew poorly in THP-1 and its growth was blocked before
accumulation of viral DNA (unpublished data), indicating
that our observation was not restricted to one cell line. Also,
no viral DNA accumulation over 96 h was evident when
peripheral macrophages were infected with HIV-1-W13 (un-
published data).
It was recently reported that some mutations in the env
region of a T cell-tropic HIV strain could abolish the already
inefficient viral growth seen in monocytes (U937), without
altering the efficient growth in T cells (SUP-Tl), and that
CD4 levels in these cell lines were comparable (4). Together
with these observations, our results suggest that viral entry
is the limiting factor for viral growth in monocytes. This is
somewhat surprising, because U937 cells have significantly
more CD4 on the cell surface than H9 cells. One possible
explanation for this is that factors other than CD4 are
involved in viral entry. For example, CD4 may have to
interact with other molecule(s), or the HIV env product may
have to interact with a second cellular protein after binding
to CD4. Such additional host component(s) may react differ-
ently with viral strains showing different tropisms. A further
possibility is that the CD4 molecule of monocytes may differ
from that of T cells, perhaps by posttranslational modifica-
tion. These explanations are also supported by the observa-
tions that CD4-expressing human and murine cells do not
support HIV growth even though the virus may bind to the
cell (3, 28).
There are certain HIV isolates, such as HIV-lBa-L, that
grow more rapidly in monocytes/macrophages than in T cells
(14). Such viruses must be able to overcome the inefficient
viral entry to monocytes seen with the T-cell tropic strains.
Because the Env protein interacts with the CD4 receptor,
studies on viral factors determining tropism have concen-
trated on this gene. For example, an HIV strain tropic for T
cells could grow in monocytes after replacement of a nucle-
otide sequence that included the env region by that from a
strain tropic for monocytes/macrophages (11). However,
Env is not the only factor determining the specificity of viral
entry, because many HIV isolates tropic for monocytes/
macrophages do not grow well in T cells which have abun-
dant CD4 (9, 14). We have recently found that the lack of
growth in T cells of HIVBa-L, a strain tropic for primary
macrophages, is likewise probably due to the inefficiency of
processes occurring between viral entry and reverse tran-
scription (unpublished data).
It has been shown in a number of independent experi-
ments that certain viral strains do not grow well in cells with
high levels of CD4 on the cell surface. These include
inefficient or no growth of macrophage-tropic viral strains in
T-lymphoid and monocytic cell lines containing high levels
of CD4 (1, 14, 25), of T-cell-tropic strain in nonreplicating
primary T cells (7, 17), and of unamplified viral strains (i.e.,
virus that has been not been passaged in cell lines in vitro
after its initial isolation from patients) in CD4-positive lym-
phoid cell lines (9). Previously, one of the most likely
explanations for such inefficient viral growth was thought to
be at the level of gene expression (9, 12). However, we have
found that in the cases described above, inefficient viral
growth is determined during the early stages of the virus life
cycle despite high levels of CD4 on the cell surface. These
observations indicate that the process of viral entry is the
result of complex interactions between host and viral factors
in addition to CD4 and gpl20 molecules. Analyzing these
interactions is a key step to understanding the pathogenetic
mechanism of HIV.
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